CDC Develops State-Level Chronic Disease Cost Calculator

Share this content:
CDC Develops State-Level Chronic Disease Cost Calculator
CDC Develops State-Level Chronic Disease Cost Calculator

TUESDAY, Sept. 15, 2015 (HealthDay News) -- A chronic disease cost calculator (CDCC) has been developed to estimate state-level costs, according to a study published online Sept. 3 in Preventing Chronic Disease.

Justin G. Trogdon, Ph.D., from the University of North Carolina at Chapel Hill, and colleagues described the development of the CDCC by the U.S. Centers for Disease Control and Prevention. They established disease-attributable annual per-person medical and absenteeism costs with publicly available and restricted secondary data from multiple national data sets from 2004 through 2008. For each disease (arthritis, asthma, cancer, congestive heart failure, coronary heart disease, hypertension, stroke, other heart disease, depression, and diabetes), the researchers derived total state medical and absenteeism costs by multiplying per-person costs from regressions by the number of people treated in the state.

The researchers found that the median state-specific medical costs varied from $410 million for asthma to $1.8 billion for diabetes. There was variation in median absenteeism costs, ranging from $5 million for congestive heart failure to $217 million for arthritis.

"CDCC provides methodologically rigorous chronic disease cost estimates," the authors write. "These estimates highlight possible areas of cost savings achievable through targeted prevention efforts or research into new interventions and treatments."

Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »